Teva Pharmaceutical

Excellent quarter from Teva, shares soar
Excellent quarter from Teva, shares soar
GoinPharma
Teva Pharmaceutical
earnings
Flag link:
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
BrainStorm Cell Therapeutics
Allergan
Pfizer
Clovis Oncology
Acorda Therapeutics
Takeda
Agios Pharmaceuticals
Shire
Teva Pharmaceutical
AbbVie
Flag link:
89Bio Joins NASH Chase with a Teva Drug and $60M in Funding
89Bio Joins NASH Chase with a Teva Drug and $60M in Funding
Xconomy
89Bio
Teva Pharmaceutical
NASH
Flag link:
Teva slumps after Express Scripts funds migraine rivals in US
Teva slumps after Express Scripts funds migraine rivals in US
Pharmaforum
PBMs
Teva Pharmaceutical
migraines
Ajovy
Express Scripts
Eli Lilly
Amgen
Flag link:
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Flag link:
Mylan's generic Copaxone wins in court, but market barriers remain
Mylan's generic Copaxone wins in court, but market barriers remain
Biopharma Dive
Teva Pharmaceutical
Copaxone
patents
MS
multiple sclerosis
Flag link:
Teva Postpones One Third of Israeli Layoffs Until 2019
Teva Postpones One Third of Israeli Layoffs Until 2019
Xtalks
Teva Pharmaceutical
drug manufacturing
layoffs
Israel
Flag link:
Gilenya beats Copaxone head-to-head at higher dose, study finds
Gilenya beats Copaxone head-to-head at higher dose, study finds
Biopharma Dive
Novartis
Teva Pharmaceutical
MS
Copaxone
Gilenya
Flag link:
FDA panel unanimously backs Celltrion's Rituxan biosimilar
FDA panel unanimously backs Celltrion's Rituxan biosimilar
Fierce Pharma
Celltrion
Teva Pharmaceutical
biosimilars
Rituxan
FDA
advisory panels
Flag link:
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
migraines
Eli Lilly
Emgality
Teva Pharmaceutical
Ajovy
Amgen
Novartis
Aimovig
Flag link:
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of its ED blockbuster
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of its ED blockbuster
Fierce Pharma
Eli Lilly
Cialis
generics
Teva Pharmaceutical
erectile dysfunction
Flag link:
The worst seems over for Teva
The worst seems over for Teva
GoinPharma
Teva Pharmaceutical
Ajovy
migraines
Flag link:
Teva wins much-needed US approval of migraine drug
Teva wins much-needed US approval of migraine drug
Biopharma Dive
Ajovy
Teva Pharmaceutical
migraines
Flag link:
Teva Is Said to Draw Interest From Recipharm, EMS for Medis Unit
Teva Is Said to Draw Interest From Recipharm, EMS for Medis Unit
Bloomberg
Teva Pharmaceutical
Medis
EMS
Recipharm
M&A
Flag link:
Teva holding off launch of opioid addiction drug
Teva holding off launch of opioid addiction drug
Pharmaforum
Teva Pharmaceutical
opioids
opioid addiction
generics
Dr Reddy's
Suboxone
Indivior
Flag link:
Teva wins FDA nod for sublingual film to treat opioid dependence
Teva wins FDA nod for sublingual film to treat opioid dependence
Drug Delivery Business News
Teva Pharmaceutical
FDA
opioids
opioid addiction
Cassipa
sublingual treatments
Flag link:
Once a blockbuster-to-be, Teva finally sounds taps for its PhIII loser laquinimod
Once a blockbuster-to-be, Teva finally sounds taps for its PhIII loser laquinimod
Endpoints
Teva Pharmaceutical
laquinimod
Flag link:
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
Flag link:
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst
Fierce Pharma
Biogen
Teva Pharmaceutical
MS
multiple sclerosis
payers
Flag link:
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
NPR
EpiPens
generics
Teva Pharmaceutical
Mylan
allergic reaction
Flag link:

Pages